Healthcare Real Estate and Pharma M&A Are Both Running Hot

German healthcare real estate transaction volume more than doubled in the first half of this year to its strongest level since 2018, while separately a major German pharmaceutical group agreed to acquire a life-science tools company for close to ten billion euros. Given how much institutional capital is chasing both the property and corporate sides of this sector, there's a clear sourcing role connecting clinic operators, medical equipment suppliers or co-investors into these parallel deal flows.